The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
Are RSV Vaccines for Babies Finally Here? CDC Panel Weighs Options for Next Season.
USA TODAY reported: On Thursday, the CDC’s Advisory Committee on Immunization Practices will discuss two RSV vaccines by pharmaceutical giants GlaxoSmithKline and Pfizer, and a monoclonal antibody by Sanofi and AstraZeneca. Here’s what we know.